Benooodly, nothing I've said is incorrect. It's great you're enthusiastic about NYR, and I am too. But there is no need to ramp.
1. Any NYR phase 2 results are not likely to be released this year or next year. For example, ARG's phase 2 was approved in Q3 2023, with expected readout Q3 2025. So best estimate for NYR phase 2 results is sometime in 2027 / 2028.
2. Even if your $7m in funding is correct, that's not enough to fund a phase 2. ARG have raised maybe $20m in that period, from memory?
3. "82 percent protection is not a partial response" - I'm not quite sure what to say. 100% is a complete response.... anything less is a partial response? And again, this is not in humans!
4. ??
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Dosing Update No 3
NYR
nyrada inc.
Add to My Watchlist
6.67%
!
24.0¢

Ann: Phase I Clinical Trial Dosing Update No 3, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $50.62M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $120.9K | 510K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 81970 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.235 |
5 | 66749 | 0.230 |
1 | 50000 | 0.225 |
5 | 206056 | 0.220 |
2 | 120005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 81970 | 1 |
0.250 | 38461 | 1 |
0.255 | 25000 | 1 |
0.260 | 54498 | 2 |
0.265 | 28500 | 2 |
Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |